Inovio Pharmaceuticals, Inc.
INO· Nasdaq
INOInovio Pharmaceuticals, Inc.
Quarterly figures for Inovio Pharmaceuticals, Inc., with source filings when available.
65 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
Inovio Pharmaceuticals, Inc. has filed its 10-Q within 39 to 45 days of period end across its last 8 quarters. The 10-K runs 60 to 77 days.
Inovio Pharmaceuticals, Inc. · CIK 1055726 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 12, 2026 · after-hours | Aug 12, 2026 | 43 d | 10-Q | $0.00 | — | -$0.07 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 13, 2026 · after-hours |
| May 13, 2026 |
| 43 d |
| 10-Q |
| $0.00 |
| −100.0% |
| -$0.28 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 12, 2026 · after-hours | Mar 12, 2026 | 71 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 10, 2025 · after-hours | Nov 10, 2025 | 41 d | 10-Q | $0.00 | — | -$0.87 | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · after-hours | Aug 12, 2025 | 43 d | 10-Q | $0.00 | −100.0% | -$0.61 | |
| Q1 2025 | Mar 31, 2025 | May 13, 2025 · after-hours | May 13, 2025 | 43 d | 10-Q | $65.34K | — | -$0.51 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 18, 2025 · after-hours | Mar 18, 2025 | 77 d | 10-K | $116.99K | +14.0% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 · after-hours | Nov 14, 2024 | 45 d | 10-Q | $0.00 | −100.0% | -$0.89 | |
| Q2 2024 | Jun 30, 2024 | Aug 8, 2024 · after-hours | Aug 8, 2024 | 39 d | 10-Q | $100.76K | −55.4% | -$1.19 | |
| Q1 2024 | Mar 31, 2024 | May 13, 2024 · after-hours | May 13, 2024 | 43 d | 10-Q | $0.00 | −100.0% | -$1.31 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | Mar 6, 2024 | 66 d | 10-K | $102.65K | −17.7% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 · after-hours | Nov 9, 2023 | 40 d | 10-Q | $388.45K | −95.8% | -$1.52 | |
| Q2 2023 | Jun 30, 2023 | Aug 9, 2023 · after-hours | Aug 9, 2023 | 40 d | 10-Q | $225.97K | −71.2% | -$1.61 | |
| Q1 2023 | Mar 31, 2023 | May 10, 2023 · after-hours | May 10, 2023 | 40 d | 10-Q | $114.94K | −42.3% | -$1.89 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 1, 2023 · after-hours | Mar 1, 2023 | 60 d | 10-K | $124.67K | −85.1% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · after-hours | Nov 8, 2022 | 39 d | 10-Q | $9.15M | +3,038.2% | -$0.15 | |
| Q2 2022 | Jun 30, 2022 | Aug 9, 2022 · after-hours | Aug 9, 2022 | 40 d | 10-Q | $784.40K | +187.5% | -$0.46 | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · after-hours | May 10, 2022 | 40 d | 10-Q | $199.07K | −46.4% | -$0.36 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Mar 1, 2022 | 60 d | 10-K | $839.12K | −85.0% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 9, 2021 | 40 d | 10-Q | $291.70K | +23.5% | -$0.29 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 9, 2021 | 40 d | 10-Q | $272.82K | +2.1% | -$0.39 | |
| Q1 2021 | Mar 31, 2021 | — | May 10, 2021 | 40 d | 10-Q | $371.12K | −72.0% | -$0.27 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | — | Mar 1, 2021 | 60 d | 10-K | $5.58M | +1,896.7% | -$0.14 | |
| Q3 2020 | Sep 30, 2020 | — | Nov 9, 2020 | 40 d | 10-Q | $236.18K | −72.8% | $0.11 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 10, 2020 | 41 d | 10-Q | $267.19K | +96.9% | -$0.83 | |
| Q1 2020 | Mar 31, 2020 | — | May 11, 2020 | 41 d | 10-Q | $1.33M | −53.1% | -$0.26 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Mar 12, 2020 | 72 d | 10-K | $279.49K | −88.8% | -$0.38 | |
| Q3 2019 | Sep 30, 2019 | — | Nov 12, 2019 | 43 d | 10-Q | $866.86K | −56.7% | -$0.25 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 8, 2019 | 39 d | 10-Q | $135.67K | −99.4% | -$0.30 | |
| Q1 2019 | Mar 31, 2019 | — | May 9, 2019 | 39 d | 10-Q | $2.83M | +85.0% | -$0.30 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | — | Mar 12, 2019 | 71 d | 10-K | $2.50M | −71.5% | -$0.34 | |
| Q3 2018 | Sep 30, 2018 | — | Nov 8, 2018 | 39 d | 10-Q | $2.00M | −24.3% | -$0.27 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 7, 2018 | 38 d | 10-Q | $24.45M | +19.8% | -$0.08 | |
| Q1 2018 | Mar 31, 2018 | — | May 9, 2018 | 39 d | 10-Q | $1.53M | −85.3% | -$0.36 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | — | Mar 14, 2018 | 73 d | 10-K | $8.79M | +3.2% | -$0.24 | |
| Q3 2017 | Sep 30, 2017 | — | Nov 8, 2017 | 39 d | 10-Q | $2.64M | −78.9% | -$0.40 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 8, 2017 | 39 d | 10-Q | $20.41M | +229.0% | -$0.13 | |
| Q1 2017 | Mar 31, 2017 | — | May 10, 2017 | 40 d | 10-Q | $10.38M | +27.9% | -$0.31 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Mar 15, 2017 | 74 d | 10-K | $8.51M | +43.4% | -$0.36 | |
| Q3 2016 | Sep 30, 2016 | — | Nov 9, 2016 | 40 d | 10-Q | $12.54M | −48.1% | -$0.28 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 8, 2016 | 39 d | 10-Q | $6.20M | +17.3% | -$0.26 | |
| Q1 2016 | Mar 31, 2016 | — | May 9, 2016 | 39 d | 10-Q | $8.11M | +57.0% | -$0.11 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | Mar 14, 2016 | 74 d | 10-K | $5.94M | +141.6% | -$0.25 | |
| Q3 2015 | Sep 30, 2015 | — | Nov 9, 2015 | 40 d | 10-Q | $24.18M | +1,214.1% | $0.07 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 10, 2015 | 41 d | 10-Q | $5.29M | +39.1% | -$0.09 | |
| Q1 2015 | Mar 31, 2015 | — | May 11, 2015 | 41 d | 10-Q | $5.17M | +119.1% | -$0.18 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2014 | — | Mar 16, 2015 | 75 d | 10-K | $2.46M | +41.2% | -$0.12 | |
| Q3 2014 | Sep 30, 2014 | — | Nov 10, 2014 | 41 d | 10-Q | $1.84M | −80.6% | -$0.12 | |
| Q2 2014 | Jun 30, 2014 | — | Aug 11, 2014 | 42 d | 10-Q | $3.80M | +383.9% | -$0.19 | |
| Q1 2014 | Mar 31, 2014 | — | May 12, 2014 | 42 d | 10-Q | $2.36M | +62.0% | -$0.20 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013 | Dec 31, 2013 | — | Mar 17, 2014 | 76 d | 10-K | $1.74M | +53.3% | -$0.30 | |
| Q3 2013 | Sep 30, 2013 | — | Nov 12, 2013 | 43 d | 10-Q | $9.49M | +1,010.0% | -$0.64 | |
| Q2 2013 | Jun 30, 2013 | — | Aug 9, 2013 | 40 d | 10-Q | $785.61K | +80.2% | -$0.24 | |
| Q1 2013 | Mar 31, 2013 | — | May 10, 2013 | 40 d | 10-Q | $1.46M | −14.1% | -$0.23 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012 | Dec 31, 2012 | — | Mar 18, 2013 | 77 d | 10-K | $1.13M | −30.5% | $0.00 | |
| Q3 2012 | Sep 30, 2012 | — | Nov 7, 2012 | 38 d | 10-Q | $854.70K | −67.6% | -$0.05 | |
| Q2 2012 | Jun 30, 2012 | — | Aug 9, 2012 | 40 d | 10-Q | $436.08K | −82.0% | -$0.03 | |
| Q1 2012 | Mar 31, 2012 | — | May 9, 2012 | 39 d | 10-Q | $1.69M | −45.5% | -$0.06 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011 | Dec 31, 2011 | — | Mar 15, 2012 | 75 d | 10-K | $1.63M | — | -$0.04 | |
| Q3 2011 | Sep 30, 2011 | — | Nov 7, 2011 | 38 d | 10-Q | $2.64M | +106.6% | -$0.04 | |
| Q2 2011 | Jun 30, 2011 | — | Aug 5, 2011 | 36 d | 10-Q | $2.42M | +113.2% | -$0.02 | |
| Q1 2011 | Mar 31, 2011 | — | May 10, 2011 | 40 d | 10-Q | $3.11M | — | -$0.02 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | Mar 16, 2011 | 75 d | 10-K | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 12, 2010 | 43 d | 10-Q | $1.28M | — | -$0.01 | |
| Q2 2010 | Jun 30, 2010 | — | Aug 13, 2010 | 44 d | 10-Q | $1.13M | — | -$0.07 | |
